Samsung Life is introducing a new health insurance product that provides payouts based on the number of cancer treatments and expands coverage from diagnosis to surgery and rehabilitation.
The company announced that it will begin selling the 'Samsung Family Representative Health Insurance Plus+ (non-participating, non-refund type)' starting on September 10.
This new product enhances the coverage of the existing 'Representative Health Insurance' series. It broadens the coverage based on the number of treatments and consolidates multiple disease diagnosis benefits into a single rider. An additional rider has been included to cover the entire treatment process, from diagnosis to tests, surgery, and rehabilitation.
The 'Integrated Cancer Coverage (up to 5 treatments per year at general hospitals or higher) and Accident Death Coverage Rider' will provide insurance payouts based on the actual number of cancer treatments received. Previously, payouts were only available after receiving two or more treatments, but the new product offers coverage starting from the first treatment.
The disease diagnosis riders have also been simplified. Samsung Life has introduced new riders such as 'Power Diagnosis (1-8 diseases)', 'Power Diagnosis II (1-5 diseases)', '50 Major Disease Diagnosis Rider', and '18 Major Disease Diagnosis Rider'. It categorizes 50 major diseases from mild to severe and bases payouts on disease codes (KCD).
Additionally, new riders for covering medical expenses incurred during treatment, including 'Integrated Disease Treatment Expense Rider' and 'Integrated Accident Treatment Expense Rider', have been established.
A Samsung Life representative stated, "We will continue to expand coverage that encompasses the entire treatment process."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.